The correlation between NF-κB p65 activation and αSMA+ cells and p-SMAD2 in primary NB tumours and the more abundant presence of p-NF-κB in TME-rich tumours provides support to our in vitro data. The gene discussed is SMAD2; the disease is neoplasm.